Skip to content
Open in App
Takeda Pharmaceutical Co logo

Takeda Pharmaceutical Co

web2

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, market...

Symbol · TAKP34
Company profile

About

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

ORZEYFUL approved in China for narcolepsy type 1

KEY STEP

China’s National Medical Products Administration approved ORZEYFUL, or oveporexton, for the treatment of narcolepsy type 1 in patients aged 16 years and older and adults.

Roadmap reference

ORZEYFUL receives United States FDA approval

KEY STEP

The United States Food and Drug Administration approved ORZEYFUL, or oveporexton, for adults with narcolepsy type 1, marking the first approved treatment designed to restore orexin signaling and address the underlying cause of the disorder.

Roadmap reference

ORZEYFUL approved in Japan for narcolepsy type 1

KEY STEP

Japan’s Ministry of Health, Labour and Welfare approved ORZEYFUL for adults with narcolepsy type 1, giving the medicine its third major regulatory approval.

Roadmap reference

MIMRYLO receives United States FDA approval for polycythemia vera

KEY STEP

The United States Food and Drug Administration approved MIMRYLO, or rusfertide, for the treatment of erythrocytosis in adults with polycythemia vera.

Roadmap reference
People

Company team

BD

Bruce Dale Broussard

Independent External Director

Company leadership profile.

MI

Masami Iijima

Independent External Chair

Company leadership profile.

JK

Julie Kim

CEO, President & Director

Company leadership profile.

MF

Milano Furuta

CFO & Director

Company leadership profile.

AS

Andrew S. Plump

President of Research & Development and Representative Director

Company leadership profile.

JM

John Michael Maraganore

Independent External Director

Company leadership profile.

KK

Koichiro Kimura

Independent External Director

Company leadership profile.

SS

Steven S. Gillis

Independent External Director

Company leadership profile.

KA

Kimberly A. Reed

Independent External Director

Company leadership profile.

MT

Miki Tsusaka

Independent External Director

Company leadership profile.

PA

Paulus A. Stoffels

Independent External Director

Company leadership profile.

Expert coverage

1 expert evaluated Takeda Pharmaceutical Co.

Orbitrum research

Experts evaluating Takeda Pharmaceutical Co

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment